EFFICACY OF OPICAPONE VERSUS ENTACAPONE IN CATECHOL-O-METHYLTRANSFERASE INHIBITOR-NAIVE PARKINSON'S DISEASE PATIENTS RECENTLY DIAGNOSED WITH MOTOR FLUCTUATIONS: A POST-HOC CONSERVATIVE ANALYSIS

被引：0
|
作者：
Ferreira, J. J. [1 ]
Lees, A. [2 ]
Ebersbach, G. [3 ]
Santos, A. [4 ]
Magalhaes, D. [5 ,6 ]
Rocha, J. -F.
Soares-da-Silva, P. [4 ,5 ,6 ,7 ]
机构：
[1] Univ Lisbon, Lab Clin Pharmacol & Therapeut, Fac Med, Lisbon, Portugal
[2] Natl Hosp Neurol & Neurosurg, Dept Clin & Movement Neurosci, London, England
[3] Beelitz Hosp, Movement Disorders Clin, Beelitz, Germany
[4] BIAL Portela & Ca SA, Dept Res & Dev, Coronado, Portugal
[5] BIAL Portela & Ca SA, Med Affairs Dept, Coronado, Portugal
[6] Univ Porto, Porto, Portugal
[7] Univ Porto, MedInUP Ctr Drug Discovery & Innovat Med, Porto, Portugal
来源：
PARKINSONISM & RELATED DISORDERS | 2020年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
A 210
引用
收藏
页码：E61 / E61
页数：1
相关论文
共 50 条
  • [41] Influence of disease severity in the efficacy response of Parkinson's disease patients with motor fluctuations: Post-hoc analysis from combined BIPARK-I and II
    Santos, A.
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Antonini, A.
    Gama, H.
    Magalhaes, D.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 656 - 656
  • [42] Influence of disease severity in the efficacy response of Parkinson's disease patients with motor fluctuations: post-hoc analysis from combined BIPARK-I and II
    Gama, H.
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Antonini, A.
    Santos, A.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S41 - S41
  • [43] Influence of disease duration in the efficacy response of Parkinson's disease patients with motor fluctuations: post-hoc analysis from combined BIPARK-I and II
    Gama, H.
    Ferreira, J.
    Lees, A.
    Antonini, A.
    Rascol, O.
    Santos, A.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S41 - S41
  • [44] Influence of disease duration in the efficacy response of Parkinson's disease patients with motor fluctuations: Post-hoc analysis from combined BIPARK-I and II
    Santos, A.
    Ferreira, J.
    Lees, A.
    Antonini, A.
    Rascol, O.
    Gama, H.
    Magalhaes, D.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 656 - 656
  • [45] Effect of one month's treatment with peripherally acting catechol-O-methyltransferase inhibitor, entacapone, on pharmacokinetics and motor response to levodopa in advanced parkinsonian patients
    Ruottinen, HM
    Rinne, UK
    CLINICAL NEUROPHARMACOLOGY, 1996, 19 (03) : 222 - 233
  • [46] Impact of 3-month earlier versus later initiation of opicapone versus entacapone in levodopa-treated patients with Parkinson's disease and motor fluctuations
    Carroll, Camille
    Lees, Andrew
    Ferreira, Joaquim
    Fonseca, Miguel
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 280 - 281
  • [47] Opicapone as First-Line Adjunctive Levodopa Treatment in Parkinson's Disease Patients with Motor Fluctuations: Findings from BIPARK-I and II Combined Post-Hoc Analysis
    Ferreira, J.
    Poewe, W.
    Antonini, A.
    Gama, H.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S447 - S448
  • [48] Opicapone as First-Line Adjunctive Levodopa Treatment in Parkinson's Disease Patients with Motor Fluctuations: Findings from BIPARK-I and II Combined Post-Hoc Analysis
    Ferreira, J. J.
    Poewe, W.
    Antonini, A.
    Gama, H.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 189 - 190
  • [49] Impact of 3-month earlier versus postponed initiation of opicapone versus entacapone in levodopa-treated patients with Parkinson's disease and motor fluctuations
    Carroll, C.
    Lees, A.
    Ferreira, J.
    Fonseca, M.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S164 - S164
  • [50] Efficacy of opicapone in Parkinson's disease patients according to baseline presence of dyskinesia: A post-hoc analysis from combined BIPARK-I and II
    Lees, A.
    Ferreira, J.
    Antonini, A.
    Reichmann, H.
    Costa, R.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
12345